Suppr超能文献

轻度卒中溶栓治疗的预测因素:佛罗里达州与波多黎各减少卒中差异合作项目

Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.

作者信息

Asdaghi Negar, Wang Kefeng, Ciliberti-Vargas Maria A, Gutierrez Carolina Marinovic, Koch Sebastian, Gardener Hannah, Dong Chuanhui, Rose David Z, Garcia Enid J, Burgin W Scott, Zevallos Juan Carlos, Rundek Tatjana, Sacco Ralph L, Romano Jose G

机构信息

From the Department of Neurology, University of Miami Miller School of Medicine, FL (N.A., K.W., M.A.C.-V., C.M.G., S.K., H.G., C.D., T.R., R.L.S., J.G.R.); Department of Neurology, University of South Florida School of Medicine, Tampa (D.Z.R., W.S.B.); Endowed Health Services Research Center, University of Puerto Rico School of Medicine, San Juan (E.J.G.); and Department of Medical and Health Sciences Research, Herbert Wertheim College of Medicine, Florida International University, Miami (J.C.Z.).

出版信息

Stroke. 2018 Mar;49(3):638-645. doi: 10.1161/STROKEAHA.117.019341. Epub 2018 Feb 19.

Abstract

BACKGROUND AND PURPOSE

Mild stroke is the most common cause for thrombolysis exclusion in patients acutely presenting to the hospital. Thrombolysis administration in this subgroup is highly variable among different clinicians and institutions. We aim to study the predictors of thrombolysis in patients with mild ischemic stroke in the FL-PR CReSD registry (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).

METHODS

Among 73 712 prospectively enrolled patients with a final diagnosis of ischemic stroke or TIA from January 2010 to April 2015, we identified 7746 cases with persistent neurological symptoms and National Institutes of Health Stroke Scale ≤5 who arrived within 4 hours of symptom onset. Multilevel logistic regression analysis with generalized estimating equations was used to identify independent predictors of thrombolytic administration in the subgroup of patients without contraindications to thrombolysis.

RESULTS

We included 6826 cases (final diagnosis mild stroke, 74.6% and TIA, 25.4%). Median age was 72 (interquartile range, 21); 52.7% men, 70.3% white, 12.9% black, 16.8% Hispanic; and median National Institutes of Health Stroke Scale, 2 (interquartile range, 3). Patients who received thrombolysis (n=1281, 18.7%) were younger (68 versus 72 years), had less vascular risk factors (hypertension, diabetes mellitus, and dyslipidemia), had lower risk of prior vascular disease (myocardial infarction, peripheral vascular disease, and previous stroke), and had a higher presenting median National Institutes of Health Stroke Scale (4 versus 2). In the multilevel multivariable model, early hospital arrival (arrive by 0-2 hours versus ≥3.5 hours; odds ratio [OR], 8.16; 95% confidence interval [CI], 4.76-13.98), higher National Institutes of Health Stroke Scale (OR, 1.87; 95% CI, 1.77-1.98), aphasia at presentation (OR, 1.35; 95% CI, 1.12-1.62), faster door-to-computed tomography time (OR, 1.81; 95% CI, 1.53-2.15), and presenting to an academic hospital (OR, 2.02; 95% CI, 1.39-2.95) were independent predictors of thrombolysis administration.

CONCLUSIONS

Mild acutely presenting stroke patients are more likely to receive thrombolysis if they are young, white, or Hispanic and arrive early to the hospital with more severe neurological presentation. Identification of predictors of thrombolysis is important in design of future studies to assess the use of thrombolysis for mild stroke.

摘要

背景与目的

轻度卒中是急性就诊患者被排除在溶栓治疗之外的最常见原因。在这一亚组患者中,不同临床医生和机构给予溶栓治疗的情况差异很大。我们旨在研究佛罗里达 - 波多黎各减少卒中差异协作登记处(FL - PR CReSD)中轻度缺血性卒中患者溶栓治疗的预测因素。

方法

在2010年1月至2015年4月前瞻性纳入的73712例最终诊断为缺血性卒中和短暂性脑缺血发作(TIA)的患者中,我们确定了7746例有持续性神经症状且美国国立卫生研究院卒中量表(NIHSS)评分≤5且在症状发作后4小时内就诊的患者。采用广义估计方程进行多水平逻辑回归分析,以确定在无溶栓治疗禁忌证的患者亚组中溶栓治疗的独立预测因素。

结果

我们纳入了6826例患者(最终诊断为轻度卒中的占74.6%,TIA的占 25.4%)。中位年龄为72岁(四分位间距为21岁);男性占52.7%,白人占70.3%,黑人占12.9%,西班牙裔占16.8%;NIHSS评分中位数为2分(四分位间距为3分)。接受溶栓治疗的患者(n = 1281,占18.7%)更年轻(68岁对72岁),血管危险因素(高血压、糖尿病和血脂异常)更少,既往血管疾病(心肌梗死、外周血管疾病和既往卒中)风险更低,且就诊时NIHSS评分中位数更高(4分对2分)。在多水平多变量模型中,早期到达医院(0 - 2小时到达对≥3.5小时到达;比值比[OR]为8.16;95%置信区间[CI]为4.76 - 13.98)、更高的NIHSS评分(OR为1.87;95% CI为1.77 - 1.98)、就诊时失语(OR为1.35;95% CI为1.12 - 1.62)、更快的从入院到计算机断层扫描时间(OR为1.81;95% CI为1.53 - 2.15)以及在学术医院就诊(OR为2.02;95% CI为1.39 - 2.95)是溶栓治疗的独立预测因素。

结论

轻度急性卒中患者如果年轻、为白人或西班牙裔且早期到达医院且神经功能表现更严重,则更有可能接受溶栓治疗。识别溶栓治疗的预测因素对于未来评估轻度卒中溶栓治疗应用的研究设计很重要。

相似文献

4
Patterns and Outcomes of Endovascular Therapy in Mild Stroke.轻度卒中血管内治疗的模式和结局。
Stroke. 2019 Aug;50(8):2101-2107. doi: 10.1161/STROKEAHA.118.023893. Epub 2019 Jul 15.

引用本文的文献

5
Outcomes in minor stroke patients treated with intravenous thrombolysis.接受静脉溶栓治疗的小卒中患者的结局。
CNS Neurosci Ther. 2023 Aug;29(8):2308-2317. doi: 10.1111/cns.14164. Epub 2023 Mar 21.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验